Showing results (1021-1030 of 1,069) with videos related to

Sort By:
Pageof 107
Journal for Immunotherapy of Cancer|April 11, 2024
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
The AAPS Journal|June 16, 2010
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyClaudia Fredolini, Francesco Meani, Alessandra Luchini, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 20, 2025
Mortality and hospitalization among older caregivers: Results from the Atherosclerosis Risk in Communities StudyShoshana H Ballew, Emmanuel E Garcia Morales, Wuyang Zhang, et al.
The Oncologist|June 23, 2025
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinomaKathryn E Beckermann, Neil J Shah, Matthew T Campbell, et al.
The Oncologist|December 28, 2022
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib TrialJames Larkin, Mototsugu Oya, Marcella Martignoni, et al.
Plos Biology|November 30, 2020
Acetylation-mediated remodeling of the nucleolus regulates cellular acetyl-CoA responsesRyan Houston, Shiori Sekine, Michael J Calderon, et al.
Clinical Genitourinary Cancer|March 20, 2018
Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial CarcinomaHamid Emamekhoo, Puneet Dhillon, Dharmesh Gopalakrishnan, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivativesMatthew J Fisher, Ryan T Backer, Iván Collado, et al.
Journal of the National Cancer Institute|October 17, 2002
Serum proteomic patterns for detection of prostate cancerEmanuel F Petricoin, David K Ornstein, Cloud P Paweletz, et al.
Clinical Genitourinary Cancer|April 29, 2020
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall SurvivalJaleh Fallah, Claudia Marcela Diaz-Montero, Patricia Rayman, et al.
Pageof 107